Thymosin Alpha 1, administered via subcutaneous injection, serves as a potent regulator of the immune system and inflammatory processes. Extensively researched as an immune-enhancing agent when used alongside flu vaccines, this 28-amino acid peptide plays a crucial role in bolstering T cell performance and antibody reactions

Prescription-Only Medication Notice:
This peptide is a Schedule 4 prescription-only treatment. Selecting this product does not guarantee access or approval. All patients must undergo a consultation with an AHPRA-registered medical practitioner, who will assess clinical suitability and determine whether this treatment is appropriate. Prescriptions are issued only when medically justified and in line with regulatory guidelines.

**All peptide therapies available through PHYX require a medical consultation and prescription. Treatment suitability is determined by an AHPRA-registered clinician.**